Report
No Thumbnail Available
Cite
Pan American Health Organization. (1988). Report [Journal articles]. https://iris.paho.org/handle/10665.2/45364
Date
1988
Document Number
ISBN
eISBN
ISSN
DOI
Other Language Versions
Description
WHO Programme Advisory Group on the Prevention of Blindness, 7. World Health Organization. Regional Office for Eastern Mediterranean; 16-19 March 1987
Notes
Pages
Volume
Replaces
Table of contents
Link to WHO's original document
Series
Link to WHO's original document
Subject
Category
Youtube URI
Citation
Status Mendates
License
Related items
Showing items related by metadata.
Item Report of the sixth meeting of the Consultative Group of Nongovernmental Organizations to the WHO Programme for the Prevention of Blindness(1994)Meeting of the Consultative Group of Nongovernmental Organizations to the WHO Programme for the Prevention of Blindness, 6. World Health Organization. Programme for the Prevention of Blindness; 22-23 Feb. 1994Item Report of the Expanded Programme on Immunization Global Advisory Group Meeting(1988)Expanded Programme on Immunization Global Advisory Group Meeting. World Health Organization; 9-13 November 1987Item Programme for Control of Diarrhoeal Diseases: Fifth programme report: 1984-1985(1986)This, the fifth report on the progress of the World Health Organization (WHO) Diarrhoeal Diseases Control (CDD) Programme, describes the activities undertaken by the Programme in the 1984-1985 biennium. The document covers the following activities and programmes. 1) Health Services Component: control strategies, programme activities, collaboration with other WHO programmes and with other agencies. 2) Research Component: research policy and management, activities of scientific working groups, research projects, collaboration with industry, collaborating centres, training courses, collaboration with other agencies and organizations, plans for reorganization of the research component. 3) Information Services. 4) Programme Review Bodies: technical advisory group, management review committee, meeting of interested parties. 5) Programme Resource and Obligations. 6) Programme Publications and Documents - 1984-1985. This document is of interest to international health professionals working with programme evaluation issuesItem Report of the Fourth Meeting of the Nongovernmental Development Organizations Group for Ivermectin Distribution(1994)Meeting of the Nongovernmental Development Organizations Coordination Group for Ivermectin Distribution, 4. World Health Organization. Programme for the Prevention of Blindness; 6-8 July 1994Item Vision impairment and blindness in individuals aged 60 years and older in Latin America and the Caribbean(2024-10-07)[ABSTRACT]. Objective. To determine the prevalence and causes of vision loss and calculate the effective cataract surgery coverage (eCSC) in adults aged 60 years and older in Latin America and the Caribbean in 2020. Methods. The International Agency for the Prevention of Blindness Vision Atlas and the Rapid Assessment of Avoidable Blindness databases were used as data source. The collected data were used to estimate the prevalence and causes of vision loss in people aged 60 years and older, and to determine the eCSC. Results. The overall prevalence of moderate to severe vision impairment (MSVI) and blindness in Latin America and the Caribbean were 14.14% and 2.94%, respectively. Tropical Latin America was the subregion with the highest prevalence of blindness (3.89%) while Southern Latin America had the lowest (0.96%). For both MSVI and blindness, cataract was the main cause of vision loss. The eCSC rates showed great variation, ranging from 4.0% in Guatemala to 75.2% in Suriname. Conclusions. The prevalence of vision loss in adults aged 60 years and older in Latin America and the Caribbean was higher than previous estimates on younger groups. Cataract was the main cause of blindness, and the eCSC indicates that the outcomes from cataract surgery should be improved. Specific actions associated with improving access, integrating eye assessment with primary care programs, expanding the use of telemedicine, and improving data quality should be taken by public health authorities aiming to address vision loss in this group.